Rhinomed Ltd (ASX:RNO) 2015 BIO International Convention Presentation
Rhinomed Ltd (ASX:RNO) announce the 2015 BIO International Convention Presentation.
Companies in the News
Biotech
Rhinomed Ltd (ASX:RNO) Sleep Apnea Trial of INPEAP Technology Receives Ethics Approval
Rhinomed Ltd (ASX:RNO), an Australian company focused on the development of novel nasal and respiratory technologies, today announced that it has received Monash Health Human Research Ethics Committee (HREC) approval for its inaugural Phase 1 sleep apnea trial featuring its new Intranasal Positive Expiratory Airway Pressure (INPEAP) technology.
Compumedics Limited (ASX:CMP) $7.5M China Sleep Contract
Compumedics Limited (ASX:CMP) is pleased to announce that it has secured a new three-year contract, for the distribution of Compumedics' sleep diagnostic and monitoring systems across provinces in North, West and Central China with its long-term distribution partner and shareholder, Beijing Bestmed.
Biotech Investors Move Ahead on the Learning Curve
Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.
Regeneus Ltd (ASX:RGS) Approval For Personalised Cancer Immunotherapy Trial
Regeneus (ASX:RGS), a clinical stage regenerative medicine company, has received ethics approval to commence its first-in-human trial for a personalised therapeutic cancer vaccine that is aimed at harnessing the body's own immune system to fight cancer cells.
Rhinomed Ltd (ASX:RNO) To Present at World Leading Biotech Convention, 2015 BIO
Rhinomed Ltd (ASX:RNO) is pleased to announce that it has been accepted as a presenter at 2015 BIO, the world's leading biotech convention to be held in Philadelphia, June 15-18th.
Rhinomed Ltd (ASX:RNO) ResMed Inc to Sell Mute Snoring and Sleep Technology Online
Australian respiratory technology company Rhinomed Ltd (ASX:RNO) has struck an important sales agreement with global sleep technology heavyweight ResMed Inc (NYSE:RMD) (ASX:RMD) to begin selling the novel Mute(TM) snoring reduction and sleep technology in the key UK market.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
- Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis
Social Media
